bufalin and Breast Cancer

bufalin has been researched along with Breast Cancer in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gong, P; Li, Y; Liu, X; Tian, X1
Gong, P; Kong, C; Li, Y; Tian, X1
Che, X; Liu, Y; Ma, Y; Qu, X; Teng, Y; Xu, L; Yan, S; Zhang, L; Zou, H1
Fang, J; Jiang, Y; Liu, Y; Luo, Y; Ma, P; Meng, F; Sui, C; Tian, X; Xu, K; Yin, H; Zhang, S1
Jia, T; Liu, C; Liu, T; Ni, Z; Sun, J; Wang, X; Xu, J; Yuan, X; Yuan, Y1
Liu, Y; Qu, X; Song, N; Teng, Y; Xu, C; Xu, L; Yan, S; Zhang, L; Zhu, Z1

Other Studies

6 other study(ies) available for bufalin and Breast Cancer

ArticleYear
Bufalin inhibits human breast cancer tumorigenesis by inducing cell death through the ROS-mediated RIP1/RIP3/PARP-1 pathways.
    Carcinogenesis, 2018, 05-03, Volume: 39, Issue:5

    Topics: Animals; Breast Neoplasms; Bufanolides; Carcinogenesis; Cell Death; Cell Line, Tumor; Female; Humans; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Nuclear Pore Complex Proteins; Poly (ADP-Ribose) Polymerase-1; Reactive Oxygen Species; Receptor-Interacting Protein Serine-Threonine Kinases; Signal Transduction

2018
Bufalin engages in RIP1-dependent and ROS-dependent programmed necroptosis in breast cancer cells by targeting the RIP1/RIP3/PGAM5 pathway.
    Anti-cancer drugs, 2019, Volume: 30, Issue:7

    Topics: Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Breast Neoplasms; Bufanolides; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Humans; Mitochondrial Proteins; Necroptosis; Nuclear Pore Complex Proteins; Phosphoprotein Phosphatases; Reactive Oxygen Species; Receptor-Interacting Protein Serine-Threonine Kinases; RNA-Binding Proteins; Tumor Cells, Cultured

2019
Bufalin enhances TRAIL-induced apoptosis by redistributing death receptors in lipid rafts in breast cancer cells.
    Anti-cancer drugs, 2014, Volume: 25, Issue:6

    Topics: Antineoplastic Agents; Apoptosis; beta-Cyclodextrins; Breast Neoplasms; Bufanolides; Cell Line, Tumor; Cholesterol; Female; Humans; Membrane Microdomains; Receptors, TNF-Related Apoptosis-Inducing Ligand; TNF-Related Apoptosis-Inducing Ligand

2014
Bufalin loaded biotinylated chitosan nanoparticles: an efficient drug delivery system for targeted chemotherapy against breast carcinoma.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2014, Volume: 87, Issue:3

    Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Bufanolides; Cell Line, Tumor; Chitosan; Drug Delivery Systems; Female; Humans; MCF-7 Cells; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Permeability; Reactive Oxygen Species; Receptors, Growth Factor

2014
Development of octreotide-conjugated polymeric prodrug of bufalin for targeted delivery to somatostatin receptor 2 overexpressing breast cancer in vitro and in vivo.
    International journal of nanomedicine, 2016, Volume: 11

    Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Bufanolides; Cell Survival; Drug Delivery Systems; Drug Liberation; Endocytosis; Female; Flow Cytometry; Humans; Hydrodynamics; MCF-7 Cells; Methacrylates; Mice, Inbred BALB C; Micelles; Octreotide; Particle Size; Polymers; Prodrugs; Receptors, Somatostatin; Tissue Distribution

2016
Down-regulation of Cbl-b by bufalin results in up-regulation of DR4/DR5 and sensitization of TRAIL-induced apoptosis in breast cancer cells.
    Journal of cancer research and clinical oncology, 2012, Volume: 138, Issue:8

    Topics: Adaptor Proteins, Signal Transducing; Animals; Apoptosis; Blotting, Western; Breast Neoplasms; Bufanolides; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Drug Synergism; Enzyme Inhibitors; Female; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-cbl; Receptors, TNF-Related Apoptosis-Inducing Ligand; RNA Interference; TNF-Related Apoptosis-Inducing Ligand; Up-Regulation; Xenograft Model Antitumor Assays

2012